• Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

  • Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

  • Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

  • Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

  • Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

  • Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

  • Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

  • Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

  • Slide

    Breast Cancer Europe Roundtable 2018

    27th June 2018, Brussels

Overview:

Breast cancer is the most common cancer in European women, with 1 in 8 developing breast cancer before the age of 85. It has the highest mortality of any cancer in women worldwide, claiming the lives of more European women than any other cancer.

Causes include an increased sedentary lifestyle, weight gain, reproductive and sociological changes.

Continued investment in research and innovation is essential for improving diagnostic accuracy and developing novel therapeutic approaches.

The EU must raise greater awareness of breast cancer through educating, highlighting the risk factors and symptoms and promoting healthier lifestyles as a preventive measure.

This roundtable meeting will bring together EU policy makers, medical and clinical professionals, academic experts, healthcare players and patient groups, to examine the ongoing challenges in managing breast cancer more effectively and explore practical solutions in order to reach an EU-wide consensus and implement a forward action plan.

At this roundtable, participants will hear from high level EU health officials and leading oncology experts, offering a variety of perspectives and recommendations through a series of open discussions.


Focus:
  • Potential for a uniform EU-wide policy
  • Data and information sharing between member states
  • Improving EU-wide collaboration and the need for a harmonised registration programme
  • Raising EU-wide awareness: education, prevention, further research and policy
  • Early detection & accurate screening and rapid diagnosis practices
  • Imaging for diagnosis – availability and accurate reading
  • Therapy options; the role of immunotherapy, chemotherapy, surgery and radiotherapy
  • How can we develop cost effective and equitable health care innovations?
  • New clinical developments and Future technologies
  • Molecular and genetic testing
Format of the day:

This event is very restricted (only 30 seats are available) and interactive. All participants will have the opportunity to offer their perspective and make contributions throughout the day.

The Roundtable will also provide hours of networking time, including coffee breaks and lunch to ensure participants have the maximum possible time to establish and strengthen relationships, whilst exchanging ideas. 

Breast Cancer Report:

Following the Roundtable, a Breast Cancer Report will be published within the Government Gazetteour official Media Partner. Contributors include the European Commission, Members of the European Parliament, academic experts, industry and other key stakeholders. 

The digital version of the 2017 report featuring Emma McClarkin MEP, Miriam Dalli MEP, Karin Kadenbach MEP, ECIBC's Donata Lerda, Dr Fatima Cardoso, etc. is available here is available here: Government Gazette online